Shiina, Kazuki
Tomiyama, Hirofumi
Tanaka, Atsushi
Yoshida, Hisako
Eguchi, Kazuo
Kario, Kazuomi
Kato, Toru
Teragawa, Hiroki
Toyoda, Shigeru
Ohishi, Mitsuru
Fukumoto, Yoshihiro
Takase, Bonpei
Ishizu, Tomoko
Node, Koichi
,
Article History
Received: 4 November 2021
Revised: 5 January 2022
Accepted: 6 January 2022
First Online: 15 February 2022
Compliance with ethical standards
:
: KS and HT were supported by Omron, Asahi Calpis Wellness and Teijin Pharma. AT has received honoraria from Boehringer Ingelheim and research funding from GlaxoSmithKline. KK received significant research grants from Teijin Pharma and Fukuda Denshi. HT has received honoraria from Abbott Medical Japan, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Kowa, Ono, Mitsubishi Tanabe, and Takeda. YF has received research grants from Sanofi KK and Shionogi & Co. Ltd; honoraria from the Public Health Research Foundation, AstraZeneca KK, Eisai Co. Ltd, and Kowa Pharmaceutical Co Ltd; and research grants and honoraria from MSD KK, Otsuka Pharmaceutical Co Ltd, Daiichi Sankyo Co Ltd, Sumitomo Dainippon Pharma Co Ltd, Teijin Pharma Ltd, Bayer Yakuhin, Ltd, Mochida Pharmaceutical Co Ltd, Astellas Pharma Inc., Sanwa Kagaku Kenkyusho Co Ltd, Takeda Pharmaceutical Co Ltd, Mitsubishi Tanabe Pharma Corp, Pfizer Japan Inc., Ono Pharmaceutical Co Ltd, and AstraZeneca KK. TI has received research grants from Ono, Daiichi Sankyo, and Teijin; has carried out joint research with Canon Medical systems and PIA; and is an employee of Tsukuba Echo Core Laboratory. KN has received honoraria from MSD, Astella, AstraZeneca, Novartis Pharma, Ono Pharmaceutical, Daiichi Sankyo, Mitsubishi Tanabe Pharma, Eli Lilly Japan, Boehringer Ingelheim Japan, and Takeda Pharmaceutical; research grants from Asahi Kasei, Astellas, Mitsubishi Tanabe Pharma, Teijin Pharma, Terumo, Boehringer Ingelheim Japan, Eli Lilly and Company, Mochida Pharmaceutical, and Fuji Yakuhin; and scholarships from Daiichi Sankyo Healthcare, Teijin Pharma, Medtronic, and Bayer Yakuhin.